Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. World Markets - 72 Indexes on 2/12/2010: Buy
27% or 19 Hold
33% or 23 Sell
40% or 28 indexes
2. Dow Jones Index - 30 Stocks on TODAY : Buy
57% or 17 Hold
30% or 9 Sell
13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010: Buy
60% or 120 Hold
20% or 40 Sell
20% or 39 stocks
4. Hot News - 200 stocks on 1/27/2010: Buy
70% or 139 Hold
-8% or -16 Sell
38% or 76 stocks
5. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
6. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
7. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
12% or 69 Hold
87% or 525 Sell
1% or 6 stocks
8. Nasdaq 100 Index - 100 Stocks on 7/21/2009: Buy
75% or 75 Hold
17% or 17 Sell
8% or 8 stocks
9. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
10. Nasdaq Biotech - 136 Stocks on 7/24/2009: Buy
57% or 78 Hold
33% or 45 Sell
10% or 13 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
68% or 2008 Hold
10% or 1393 Sell
22% or 527 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
3/5/2010 Friday, March 05, 2010 (Irvine, California) Today StockRing.com Recommendation is to "SUPER SELL-SHORT"for Pfize (17.23 - 17.42:PFE) Stock.
PFE stock opening price was $17.37 per share.
Current price of 17.23 - 17.42:PFE Stock is $17.36 per share
and it is
$+0.03, (+0.17%) today
and it was trading in the daily range of $380160 per share.
Current Bid Price for (17.23 - 17.42:PFE) stock is $3.81 and the Ask Price is $17.36. In the last 52 weeks
PFE stock was trading in the range of $12.25 - 20.36. 50-Day Moving Average for (17.23 - 17.42:PFE) stock is
$19.905B and 200-Day Moving Average is $18.334. On average analysts predict that One Year Target Estimated price for
(17.23 - 17.42:PFE) stock is $17.6534.
Pfize (17.23 - 17.42:PFE) Market capitalization is $140.1B. (17.23 - 17.42:PFE) stock average daily volume is
N/A shares per day.
However, on last trading session of 1:43pm, 2009
PFE stock traded 39,948,244 shares.
Also The Short Ratio for (17.23 - 17.42:PFE) stock is 50.009B.
On previous trading session PFE Stock closed at $17.33 per share.
Last year Pfize (17.23 - 17.42:PFE) before taxes (EBITDA) (ttm) earned $17.37 on total revenue of $2.12.
Earnings Per Share - EPS (ttm) for PFE stock is 1.226.
Also, (17.23 - 17.42:PFE) Stock Price Per Earnings ratio - P/E is 14.14.
Thus, (17.23 - 17.42:PFE) Stock Price/Sales (ttm) ratio is 21.97 and Price/Book (mrq) ratio is 2.80.
(17.23 - 17.42:PFE) Stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%.
So at this time (17.23 - 17.42:PFE) Stock maintains Trailing Annual Dividend Rate at 0.70.
StockRing Recommendations for Pfize (17.23 - 17.42:PFE) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=PFE
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
PFE Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
3/5/2010
1 Year Stock market price chart for Pfize (17.23 - 17.42:PFE) Stock on Friday, March 05, 2010
|
 | |
| 1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
| 1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
|
3/5/2010
5 days Stock market price chart for Pfize (17.23 - 17.42:PFE) Stock on Friday, March 05, 2010
|
| |
| 5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
| 5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
PFE Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
| Last Trade: |
17.36 |
| Trade Time: |
1:43pm |
| Change: |
+0.03, (+0.17%) |
| Prev Close: |
17.33 |
| Open: |
17.37 |
| Bid: |
3.81 |
| Ask: |
0.66 |
| 1y Target Est: |
$17.6534 |
| 50-Day Moving Average: |
19.905B |
200-Day Moving Average:
|
18.334 |
| Short Ratio: |
50.009B |
| Trailing Annual Dividend Rate: |
0.70 |
|
| Day's Range: |
380160 |
| 52wk Range: |
12.25 - 20.36 |
| Volume: |
39,948,244 |
| Avg Vol: |
N/A |
| Market Cap: |
140.1B |
| P/E (ttm): |
14.14 |
| EPS (ttm): |
1.226 |
| Div & Yield: |
Inc. Comm" ("NYSE"%) |
| Revenue (ttm): |
2.12 |
| Earnings before Tax (EBITDA) (ttm): |
17.37 |
| Price/Sales (ttm): |
21.97 |
| Price/Book (mrq): |
2.80 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
|
|
EUROs for $1 DOLLAR: 30 days |
 | |
|
PFIZER INC(NYSE: PFE) Company Information
Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States - Map
Phone: 212-573-2323
Fax: 212-573-7851
Web Site: http://www.pfizer.com
PFIZER INC(NYSE: PFE) DETAILS
PFIZER INC(NYSE: PFE) Index Membership: Dow Jones Composite
Dow Industrials
S&P 100
S&P 500
S&P 1500 Super Comp
PFIZER INC(NYSE: PFE) Sector: Healthcare
PFIZER INC(NYSE: PFE) Industry: Drug Manufacturers - Major
PFIZER INC(NYSE: PFE) Full Time Employees: 75,400
PFIZER INC(NYSE: PFE) BUSINESS SUMMARY
Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.
PFIZER INC(NYSE: PFE) KEY EXECUTIVES
Mr. Jeffrey B. Kindler , 53
Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Exec. Compliance Committee $ 4.58M $ 0
Mr. Frank A. D'Amelio , 51
Chief Financial Officer, Sr. VP of Bus. Operations and Member of Exec. Compliance Committee $ 2.30M $ 0
Mr. Ian C. Read , 55
Group Pres of Worldwide Biopharmaceutical Bus.es and Member of Exec. Compliance Committee $ 2.30M $ 0
Mr. Martin Mackay , 52
Pres of PharmaTherapeutics R&D $ 2.29M $ 0
Mr. Natale S. Ricciardi , 60
Pres of Manufacturing N/A N/A
|
1. World Markets - 72 Indexes on 2/12/2010: Buy
27% or 19 Hold
33% or 23 Sell
40% or 28 indexes
2. Dow Jones Index - 30 Stocks on TODAY : Buy
57% or 17 Hold
30% or 9 Sell
13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010: Buy
60% or 120 Hold
20% or 40 Sell
20% or 39 stocks
4. Hot News - 200 stocks on 1/27/2010: Buy
70% or 139 Hold
-8% or -16 Sell
38% or 76 stocks
5. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
6. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
7. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
12% or 69 Hold
87% or 525 Sell
1% or 6 stocks
8. Nasdaq 100 Index - 100 Stocks on 7/21/2009: Buy
75% or 75 Hold
17% or 17 Sell
8% or 8 stocks
9. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
10. Nasdaq Biotech - 136 Stocks on 7/24/2009: Buy
57% or 78 Hold
33% or 45 Sell
10% or 13 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
68% or 2008 Hold
10% or 1393 Sell
22% or 527 stocks
SCANCELL HOLDINGS PLC - Open Offer
Behavioral Health Central - 3 hours ago
5 March 2010 Scancell Holdings Plc (the "Company") Open Offer of 5,137,775 New Ordinary Shares at 45 pence per share to raise £2.31 million Scancell Holdings Plc, (PLUS:SCLP), the developer of ...
Pfizer Cholesterol Flops Cleared Path for Resverlogix
Bloomberg - 4 hours ago
By Ellen Gibson March 5 (Bloomberg) -- Resverlogix Corp., without a marketed product, may accomplish what Pfizer Inc., the world's biggest drugmaker, couldn't: Creating a new medicine that fights ...
|
|
Free StockRing iPhone App for 1,200 stocks !!!
No comments:
Post a Comment